Mendelian is a brand dedicated to helping doctors find early diagnoses for rare and hard-to-diagnose diseases. With a mission to end the diagnostic odyssey, Mendelian focuses on diseases that affect 1 in 17 people worldwide. These rare diseases often present with complex and disconnected symptoms throughout a person's life, making them difficult to diagnose and costly for families, doctors, and healthcare providers.

Through their clinician-led approach, Mendelian has developed tools that are easy to use and act on within medical practices, ensuring efficiency and improved patient care. Their expert-guided platform, MendelScan, encodes case finding criteria for hard-to-diagnose diseases, making it a valuable resource for disease discovery. Their digital solutions are also implemented within the NHS, the largest national healthcare system globally.

Mendelian prioritizes patients by creating ethical solutions and maintaining strong ties with patient groups. By remaining connected to patient challenges, needs, and values, Mendelian strives to provide solutions that prioritize patient well-being. The Mendelian team consists of highly qualified professionals, including medical doctors, computer scientists, advisors, and clinical leads.

Their expertise and dedication contribute to the brand's success in advancing rare disease diagnosis. Overall, Mendelian's brand is centered around improving early diagnoses for rare diseases, empowering doctors, and bringing timely patient insights to primary care